NEURALINK WILL START HIGH-VOLUME PRODUCTION OF BRAIN-COMPUTER INTERFACE DEVICES IN 2026

Summary from the TLDR newsletter

Neuralink received FDA breakthrough device designation for its speech restoration in 2025. The company also launched clinical trials in the Middle East and the UK, and completed two surgeries in Canada. It upgraded its surgical robot to be able to insert an electrode thread every 1.5 seconds at insertion depths of over 50mm. The threads go through the dura without the need to remove it. Neuralink plans to move to an almost completely automated surgical procedure this year.